Molecular Recognition of Agonist and Antagonist for Peroxisome Proliferator-Activated Receptor-α Studied by Molecular Dynamics Simulations

被引:6
作者
Liu, Mengyuan [1 ]
Wang, Lushan [2 ]
Zhao, Xian [1 ]
Sun, Xun [1 ]
机构
[1] Shandong Univ, State Key Lab Crystal Mat, Jinan 250100, Peoples R China
[2] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China
关键词
PPAR-alpha; molecular modeling; diabetes; PARTICLE-MESH EWALD; LINEAR CONSTRAINT SOLVER; PPAR-ALPHA; ACID; GROMACS; DESIGN; LIGAND; GAMMA; SELECTIVITY; RESPONSES;
D O I
10.3390/ijms15058743
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Peroxisome proliferator activated receptor-alpha (PPAR-alpha) is a ligand-activated transcription factor which plays important roles in lipid and glucose metabolism. The aim of this work is to find residues which selectively recognize PPAR-alpha agonists and antagonists. To achieve this aim, PPAR-alpha/13M and PPAR-alpha/471 complexes were subjected to perform molecular dynamics simulations. This research suggests that several key residues only participate in agonist recognition, while some other key residues only contribute to antagonist recognition. It is hoped that such work is useful for medicinal chemists to design novel PPAR-alpha agonists and antagonists.
引用
收藏
页码:8743 / 8752
页数:10
相关论文
共 50 条
  • [21] Salidroside Ameliorates Cardiomyocyte Hypertrophy by Upregulating Peroxisome Proliferator-Activated Receptor-α
    Gao, Hui
    Tian, Kunming
    Meng, Yichong
    Liu, Xueping
    Peng, Yingfu
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [22] Role of peroxisome proliferator-activated receptor-α in acute pancreatitis induced by cerulein
    Genovese, Tiziana
    Mazzon, Emanuela
    Di Paola, Rosanna
    Muia, Carmelo
    Crisafulli, Concetta
    Malleo, Giuseppe
    Esposito, Emanuela
    Cuzzocrea, Salvatore
    IMMUNOLOGY, 2006, 118 (04) : 559 - 570
  • [23] Molecular mechanisms and therapeutic perspectives of peroxisome proliferator-activated receptor α agonists in cardiovascular health and disease
    Pu, Yujie
    Cheng, Chak Kwong
    Zhang, Hongsong
    Luo, Jiang-Yun
    Wang, Li
    Tomlinson, Brian
    Huang, Yu
    MEDICINAL RESEARCH REVIEWS, 2023, 43 (06) : 2086 - 2114
  • [24] Peroxisome proliferator-activated receptor-α expression is associated with histological type in human gastric carcinoma
    Morinishi, Tatsuya
    Tokuhara, Yasunori
    Kajihara, Kazuki
    Kawakami, Shunsei
    Tanaka, Shinichi
    Ohsaki, Hiroyuki
    Matsunaga, Toru
    Ibuki, Emi
    Hirakawa, Eiichiro
    MOLECULAR AND CLINICAL ONCOLOGY, 2022, 16 (02)
  • [25] Activation of peroxisome proliferator-activated receptor-α enhances fatty acid oxidation in human adipocytes
    Lee, Joo-Young
    Hashizaki, Hikari
    Goto, Tsuyoshi
    Sakamoto, Tomoya
    Takahashi, Nobuyuki
    Kawada, Teruo
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 407 (04) : 818 - 822
  • [26] Peroxisome proliferator-activated receptor-γ ligands as investigational modulators of angiogenesis
    Giaginis, Costas
    Margeli, Alexandra
    Theocharis, Stamatios
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (10) : 1561 - 1572
  • [27] Peroxisome proliferator-activated receptor-/ modulates mast cell phenotype
    Yao, Pei-Li
    Morales, Jose L.
    Gonzalez, Frank J.
    Peters, Jeffrey M.
    IMMUNOLOGY, 2017, 150 (04) : 456 - 467
  • [28] Berberine is a potent agonist of peroxisome proliferator activated receptor alpha
    Yu, Huarong
    Li, Changqing
    Yang, Junqing
    Zhang, Tao
    Zhou, Qixin
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2016, 21 : 1052 - 1060
  • [29] Potent peroxisome proliferator-activated receptor-α agonist treatment increases cholesterol efflux capacity in humans with the metabolic syndrome
    Khera, Amit V.
    Millar, John S.
    Ruotolo, Giacomo
    Wang, Ming-Dauh
    Rader, Daniel J.
    EUROPEAN HEART JOURNAL, 2015, 36 (43) : 3020 - 3022
  • [30] Bidirectional fluorescence properties of pyrene-based peroxisome proliferator-activated receptor (PPAR) α/δ dual agonist
    Ban, Shintaro
    Oyama, Takuji
    Kasuga, Jun-ichi
    Ohgane, Kenji
    Nishio, Yoshino
    Morikawa, Kosuke
    Hashimoto, Yuichi
    Miyachi, Hiroyuki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (11) : 3460 - 3464